CL
HOLX

Choreo LLC’s Hologic HOLX Stock Holding History

Choreo LLC’s Portfolio HOLX Stock Details HOLX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-6,484
Closed -$490K – 1731
2026
Q1 		$490K Sell
6,484
-593
-8% -$44.6K 0.01% 947
2025
Q4 		$528K Buy
7,077
+2,849
+67% +$208K 0.01% 898
2025
Q3 		$285K Buy
4,228
+372
+10% +$24.7K ﹤0.01% 1256
2025
Q2 		$251K Buy
3,856
+111
+3% +$6.65K ﹤0.01% 1283
2025
Q1 		$231K Sell
3,745
-2,901
-44% -$192K ﹤0.01% 1237
2024
Q4 		$480K Buy
6,646
+825
+14% +$64.5K 0.01% 929
2024
Q3 		$469K Buy
5,821
+523
+10% +$41.8K 0.01% 945
2024
Q2 		$393K Buy
+5,298
New +$397K 0.01% 938

Other funds holding HOLX

DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Choreo LLC's HOLX Position: Q2 2026 in Review

Choreo LLC sold out of Hologic (HOLX) in Q2 2026, closing a stake of 6,484 shares — an estimated $490K sold.

Choreo LLC first reported a position in HOLX in Q2 2024 and held it in 8 quarters. The position peaked at $528K in Q4 2025. 3 funds tracked by Wall St. Rank hold HOLX as of Q2 2026.

  • Choreo LLC reported no remaining Hologic position as of Q2 2026 after selling out during the quarter.
  • Choreo LLC sold 6,484 Hologic shares in Q2 2026, an estimated $490K.
  • Choreo LLC first reported a position in Hologic in Q2 2024 and held it in 8 quarters.
  • Choreo LLC's Hologic position peaked at $528K in Q4 2025.
  • 3 funds tracked by Wall St. Rank held Hologic as of Q2 2026.

Based on Choreo LLC's 13F filing for Q2 2026, filed 4 Aug 2026.